Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

Restricted access

Vulvar cancer is a rare gynecologic malignancy. Ninety percent of vulvar cancers are predominantly squamous cell carcinomas (SCCs), which can arise through human papilloma virus (HPV)–dependent and HPV-independent pathways. The NCCN Vulvar Cancer panel is an interdisciplinary group of representatives from NCCN Member Institutions consisting of specialists in gynecological oncology, medical oncology, radiation oncology, and pathology. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Vulvar Cancer provide an evidence- and consensus-based approach for the management of patients with vulvar SCC. This manuscript discusses the recommendations outlined in the NCCN Guidelines for diagnosis, staging, treatment, and follow-up.

  • 1.

    SEER Cancer Statistics Factsheets: Vulvar Cancer. Bethesda, MD: National Cancer Institute; Available at: http://seer.cancer.gov/statfacts/html/vulva.html. Accessed April 22, 2016.

    • Search Google Scholar
    • Export Citation
  • 2.

    Vulvar Cancer Treatment (PDQ®)–Health Professional Version. Bethesda, MD: 2015. Available at: http://www.cancer.gov/types/vulvar/hp/vulvar-treatment-pdq#section/_1. Accessed August 3, 2015.

    • Search Google Scholar
    • Export Citation
  • 3.

    Tergas AI, Tseng JH, Bristow RE. Impact of race and ethnicity on treatment and survival of women with vulvar cancer in the United States. Gynecol Oncol 2013;129:154158.

    • Search Google Scholar
    • Export Citation
  • 4.

    Chase DM, Lin CC, Craig CD. Disparities in vulvar cancer reported by the National Cancer Database: influence of sociodemographic factors. Obstet Gynecol 2015;126:792802.

    • Search Google Scholar
    • Export Citation
  • 5.

    Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol 2008;108:577583.

    • Search Google Scholar
    • Export Citation
  • 6.

    Figge DC. Rare vulvar malignancies. In: Greer BE, Berek JS, eds. Current Topics In Obstetrics And Gynecology: Gynecologic Oncology: Treatment Rationale And Techniques. Elsevier; 1991:239257.

    • Search Google Scholar
    • Export Citation
  • 7.

    Sideri M, Jones RW, Wilkinson EJ. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005;50:807810.

    • Search Google Scholar
    • Export Citation
  • 8.

    Bornstein J, Bogliatto F, Haefner HK. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology of vulvar squamous intraepithelial lesions. Obstet Gynecol 2016;127:264268.

    • Search Google Scholar
    • Export Citation
  • 9.

    Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113:30363046.

    • Search Google Scholar
    • Export Citation
  • 10.

    Watson M, Saraiya M, Ahmed F. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer 2008;113:28412854.

    • Search Google Scholar
    • Export Citation
  • 11.

    Gargano JW, Wilkinson EJ, Unger ER. Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis 2012;16:471479.

    • Search Google Scholar
    • Export Citation
  • 12.

    Eifel PJ, Berek JS, Markman MA. Cancer of the cervix, vagina, and vulva. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Principles and Practice of Oncology, 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011:13111344.

    • Search Google Scholar
    • Export Citation
  • 13.

    Hampl M, Deckers-Figiel S, Hampl JA. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol 2008;109:340345.

  • 14.

    van der Velden J, Fons G, Lawrie TA. Primary groin irradiation versus primary groin surgery for early vulvar cancer. Cochrane Database Syst Rev 2011:CD002224.

    • Search Google Scholar
    • Export Citation
  • 15.

    Wills A, Obermair A. A review of complications associated with the surgical treatment of vulvar cancer. Gynecol Oncol 2013;131:467479.

  • 16.

    Reade CJ, Eiriksson LR, Mackay H. Systemic therapy in squamous cell carcinoma of the vulva: current status and future directions. Gynecol Oncol 2014;132:780789.

    • Search Google Scholar
    • Export Citation
  • 17.

    van Doorn HC, Ansink A, Verhaar-Langereis M, Stalpers L. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev 2006:CD003752.

    • Search Google Scholar
    • Export Citation
  • 18.

    Shylasree TS, Bryant A, Howells RE. Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev 2011:CD003752.

  • 19.

    Woelber L, Kock L, Gieseking F. Clinical management of primary vulvar cancer. Eur J Cancer 2011;47:23152321.

  • 20.

    Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet 2009;105:105106.

  • 21.

    Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103104.

  • 22.

    Amin MB, Edge SB, Greene FL. AJCC Cancer Staging Manual, 8th edition. New York, NY: Springer; 2016.

  • 23.

    Li J, Cai Y, Ke G. Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population. Gynecol Oncol 2015;137:274279.

    • Search Google Scholar
    • Export Citation
  • 24.

    Tabbaa ZM, Gonzalez J, Sznurkowski JJ. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution. Gynecol Oncol 2012;127:147152.

    • Search Google Scholar
    • Export Citation
  • 25.

    Tan J, Chetty N, Kondalsamy-Chennakesavan S. Validation of the FIGO 2009 staging system for carcinoma of the vulva. Int J Gynecol Cancer 2012;22:498502.

    • Search Google Scholar
    • Export Citation
  • 26.

    Greer BE, Berek JS. Evolution of the primary treatment of invasive squamous cell carcinoma of the vulva. In: Greer BE, Berek JS, eds. Current Topics In Obstetrics And Gynecology: Gynecologic Oncology: Treatment Rationale And Techniques: Elsevier; 1991:227238.

    • Search Google Scholar
    • Export Citation
  • 27.

    Kataoka MY, Sala E, Baldwin P. The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-centre study. Gynecol Oncol 2010;117:8287.

    • Search Google Scholar
    • Export Citation
  • 28.

    Cohn DE, Dehdashti F, Gibb RK. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 2002;85:179184.

    • Search Google Scholar
    • Export Citation
  • 29.

    Kamran MW, O'Toole F, Meghen K. Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan as combined PET-CT staging prior to planned radical vulvectomy and inguinofemoral lymphadenectomy for squamous vulvar cancer: a correlation with groin node metastasis. Eur J Gynaecol Oncol 2014;35:230235.

    • Search Google Scholar
    • Export Citation
  • 30.

    Peiro V, Chiva L, Gonzalez A. [Utility of the PET/CT in vulvar cancer management]. Rev Esp Med Nucl Imagen Mol 2014;33:8792 [in Spanish].

  • 31.

    Robertson NL, Hricak H, Sonoda Y. The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer. Gynecol Oncol 2016;140:420424.

    • Search Google Scholar
    • Export Citation
  • 32.

    Homesley HD, Bundy BN, Sedlis A. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991;164:9971003; discussion 1003–1004.

    • Search Google Scholar
    • Export Citation
  • 33.

    Burger MP, Hollema H, Emanuels AG. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 1995;57:327334.

    • Search Google Scholar
    • Export Citation
  • 34.

    Maggino T, Landoni F, Sartori E. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer 2000;89:116122.

    • Search Google Scholar
    • Export Citation
  • 35.

    van der Velden J, van Lindert AC, Lammes FB. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer 1995;75:28852890.

    • Search Google Scholar
    • Export Citation
  • 36.

    Luchini C, Nottegar A, Solmi M. Prognostic implications of extranodal extension in node-positive squamous cell carcinoma of the vulva: a systematic review and meta-analysis. Surg Oncol 2016;25:6065.

    • Search Google Scholar
    • Export Citation
  • 37.

    Origoni M, Sideri M, Garsia S. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol 1992;45:313316.

    • Search Google Scholar
    • Export Citation
  • 38.

    Raspagliesi F, Hanozet F, Ditto A. Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva. Gynecol Oncol 2006;102:333337.

    • Search Google Scholar
    • Export Citation
  • 39.

    Heaps JM, Fu YS, Montz FJ. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990;38:309314.

    • Search Google Scholar
    • Export Citation
  • 40.

    Homesley HD, Bundy BN, Sedlis A. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol 1993;49:279283.

    • Search Google Scholar
    • Export Citation
  • 41.

    Aragona AM, Cuneo NA, Soderini AH, Alcoba EB. An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: is tumor size significance being underrated? Gynecol Oncol 2014;132:643648.

    • Search Google Scholar
    • Export Citation
  • 42.

    Rouzier R, Haddad B, Plantier F. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 2002;100:11591167.

    • Search Google Scholar
    • Export Citation
  • 43.

    Figge DC, Tamimi HK, Greer BE. Lymphatic spread in carcinoma of the vulva. Am J Obstet Gynecol 1985;152:387394.

  • 44.

    Farias-Eisner R, Cirisano FD, Grouse D. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. Gynecol Oncol 1994;53:5558.

    • Search Google Scholar
    • Export Citation
  • 45.

    Stehman FB, Look KY. Carcinoma of the vulva. Obstet Gynecol 2006;107:719733.

  • 46.

    Landrum LM, Lanneau GS, Skaggs VJ. Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era. Gynecol Oncol 2007;106:521525.

    • Search Google Scholar
    • Export Citation
  • 47.

    Kim KW, Shinagare AB, Krajewski KM. Update on imaging of vulvar squamous cell carcinoma. AJR Am J Roentgenol 2013;201:W147157.

  • 48.

    Slomovitz BM, Coleman RL, Oonk MH. Update on sentinel lymph node biopsy for early-stage vulvar cancer. Gynecol Oncol 2015;138:472477.

  • 49.

    Magrina JF, Gonzalez-Bosquet J, Weaver AL. Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery. Gynecol Oncol 1998;71:116121.

    • Search Google Scholar
    • Export Citation
  • 50.

    Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev 2000:CD002036.

    • Search Google Scholar
    • Export Citation
  • 51.

    DeSimone CP, Van Ness JS, Cooper AL. The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus. Gynecol Oncol 2007;104:390395.

    • Search Google Scholar
    • Export Citation
  • 52.

    De Hullu JA, Hollema H, Lolkema S. Vulvar carcinoma. The price of less radical surgery. Cancer 2002;95:23312338.

  • 53.

    Viswanathan AN, Pinto AP, Schultz D. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol 2013;130:545549.

    • Search Google Scholar
    • Export Citation
  • 54.

    Chan JK, Sugiyama V, Pham H. Margin distance and other clinicopathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 2007;104:636641.

    • Search Google Scholar
    • Export Citation
  • 55.

    Faul CM, Mirmow D, Huang Q. Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 1997;38:381389.

  • 56.

    Woelber L, Eulenburg C, Grimm D. The risk of contralateral non-sentinel metastasis in patients with primary vulvar cancer and unilaterally positive sentinel node. Ann Surg Oncol 2016;23:25082514.

    • Search Google Scholar
    • Export Citation
  • 57.

    Coleman RL, Ali S, Levenback CF. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol 2013;128:155159.

    • Search Google Scholar
    • Export Citation
  • 58.

    DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol 1979;133:825832.

  • 59.

    Van der Zee AG, Oonk MH, De Hullu JA. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;26:884889.

    • Search Google Scholar
    • Export Citation
  • 60.

    Oonk MH, van Hemel BM, Hollema H. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010;11:646652.

    • Search Google Scholar
    • Export Citation
  • 61.

    Oonk MH, van Os MA, de Bock GH. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol 2009;113:301305.

    • Search Google Scholar
    • Export Citation
  • 62.

    Te Grootenhuis NC, van der Zee AG, van Doorn HC. Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol 2016;140:814.

    • Search Google Scholar
    • Export Citation
  • 63.

    Levenback CF, Ali S, Coleman RL. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 2012;30:37863791.

    • Search Google Scholar
    • Export Citation
  • 64.

    Covens A, Vella ET, Kennedy EB. Sentinel lymph node biopsy in vulvar cancer: systematic review, meta-analysis and guideline recommendations. Gynecol Oncol 2015;137:351361.

    • Search Google Scholar
    • Export Citation
  • 65.

    Hacker NF, Berek JS, Lagasse LD. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 1984;63:155162.

  • 66.

    Burke TW, Levenback C, Coleman RL. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995;57:215220.

    • Search Google Scholar
    • Export Citation
  • 67.

    Hacker NF, Van der Velden J. Conservative management of early vulvar cancer. Cancer 1993;71:16731677.

  • 68.

    Morgan MA, Mikuta JJ. Surgical management of vulvar cancer. Semin Surg Oncol 1999;17:168172.

  • 69.

    Stehman FB, Bundy BN, Thomas G. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1992;24:389396.

    • Search Google Scholar
    • Export Citation
  • 70.

    Hallak S, Ladi L, Sorbe B. Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma. Int J Oncol 2007;31:10771085.

    • Search Google Scholar
    • Export Citation
  • 71.

    Petereit DG, Mehta MP, Buchler DA, Kinsella TJ. Inguinofemoral radiation of N0,N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used. Int J Radiat Oncol Biol Phys 1993;27:963967.

    • Search Google Scholar
    • Export Citation
  • 72.

    Rouzier R, Haddad B, Atallah D. Surgery for vulvar cancer. Clin Obstet Gynecol 2005;48:869878.

  • 73.

    Magrina JF, Gonzalez-Bosquet J, Weaver AL. Squamous cell carcinoma of the vulva stage IA: long-term results. Gynecol Oncol 2000;76:2427.

  • 74.

    Yoder BJ, Rufforny I, Massoll NA, Wilkinson EJ. Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk. Am J Surg Pathol 2008;32:765772.

    • Search Google Scholar
    • Export Citation
  • 75.

    Wilkinson EJ. Superficial invasive carcinoma of the vulva. Clin Obstet Gynecol 1985;28:188195.

  • 76.

    Forner DM, Lampe B. Exenteration in the treatment of stage III/IV vulvar cancer. Gynecol Oncol 2012;124:8791.

  • 77.

    Miller B, Morris M, Levenback C. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol 1995;58:202205.

  • 78.

    Hoffman MS, Cavanagh D, Roberts WS. Ultraradical surgery for advanced carcinoma of the vulva: an update. Int J Gynecol Cancer 1993;3:369372.

    • Search Google Scholar
    • Export Citation
  • 79.

    Gadducci A, Cionini L, Romanini A. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 2006;60:227241.

    • Search Google Scholar
    • Export Citation
  • 80.

    Boronow RC. Combined therapy as an alternative to exenteration for locally advanced vulvo-vaginal cancer: rationale and results. Cancer 1982;49:10851091.

    • Search Google Scholar
    • Export Citation
  • 81.

    Fuh KC, Berek JS. Current management of vulvar cancer. Hematol Oncol Clin North Am 2012;26:4562.

  • 82.

    Leiserowitz GS, Russell AH, Kinney WK. Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol 1997;66:509514.

    • Search Google Scholar
    • Export Citation
  • 83.

    Russell AH, Mesic JB, Scudder SA. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 1992;47:1420.

    • Search Google Scholar
    • Export Citation
  • 84.

    Thomas G, Dembo A, DePetrillo A. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 1989;34:263267.

  • 85.

    Eifel PJ, Morris M, Burke TW. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol 1995;59:5156.

    • Search Google Scholar
    • Export Citation
  • 86.

    Lupi G, Raspagliesi F, Zucali R. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer 1996;77:14721478.

    • Search Google Scholar
    • Export Citation
  • 87.

    Moore DH, Thomas GM, Montana GS. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:7985.

    • Search Google Scholar
    • Export Citation
  • 88.

    Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol 2006;100:5357.

  • 89.

    Landoni F, Maneo A, Zanetta G. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 1996;61:321327.

    • Search Google Scholar
    • Export Citation
  • 90.

    Berek JS, Heaps JM, Fu YS. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 1991;42:197201.

    • Search Google Scholar
    • Export Citation
  • 91.

    Koh WJ, Wallace HJ III, Greer BE. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 1993;26:809816.

    • Search Google Scholar
    • Export Citation
  • 92.

    Cunningham MJ, Goyer RP, Gibbons SK. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol 1997;66:258261.

    • Search Google Scholar
    • Export Citation
  • 93.

    Gerszten K, Selvaraj RN, Kelley J, Faul C. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol 2005;99:640644.

    • Search Google Scholar
    • Export Citation
  • 94.

    Tans L, Ansink AC, van Rooij PH. The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol 2011;34:2226.

    • Search Google Scholar
    • Export Citation
  • 95.

    Han SC, Kim DH, Higgins SA. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2000;47:12351244.

    • Search Google Scholar
    • Export Citation
  • 96.

    Montana GS, Thomas GM, Moore DH. Preoperative chemoradiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2000;48:10071013.

    • Search Google Scholar
    • Export Citation
  • 97.

    Moore DH, Ali S, Koh WJ. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol 2012;124:529533.

    • Search Google Scholar
    • Export Citation
  • 98.

    Chin JY, Hong TS, Ryan DP. Mitomycin in anal cancer: still the standard of care. J Clin Oncol 2012;30:42974301.

  • 99.

    Han SN, Vergote I, Amant F. Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer. Int J Gynecol Cancer 2012;22:865868.

    • Search Google Scholar
    • Export Citation
  • 100.

    Witteveen PO, van der Velden J, Vergote I. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG. Ann Oncol 2009;20:15111516.

    • Search Google Scholar
    • Export Citation
  • 101.

    Horowitz NS, Olawaiye AB, Borger DR. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol 2012;127:141146.

    • Search Google Scholar
    • Export Citation
  • 102.

    Jolly S, Soni P, Gaffney DK. ACR Appropriateness Criteria(R) adjuvant therapy in vulvar cancer. Oncology (Williston Park) 2015;29:867872.

  • 103.

    Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986;68:733740.

    • Search Google Scholar
    • Export Citation
  • 104.

    Kunos C, Simpkins F, Gibbons H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol 2009;114:537546.

    • Search Google Scholar
    • Export Citation
  • 105.

    Fons G, Groenen SM, Oonk MH. Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol 2009;114:343345.

    • Search Google Scholar
    • Export Citation
  • 106.

    Mahner S, Jueckstock J, Hilpert F. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 2015;107:pii: dju426.

    • Search Google Scholar
    • Export Citation
  • 107.

    Parthasarathy A, Cheung MK, Osann K. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol 2006;103:10951099.

    • Search Google Scholar
    • Export Citation
  • 108.

    Woelber L, Eulenburg C, Choschzick M. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer 2012;22:503508.

    • Search Google Scholar
    • Export Citation
  • 109.

    Dusenbery KE, Carlson JW, LaPorte RM. Radical vulvectomy with postoperative irradiation for vulvar cancer: therapeutic implications of a central block. Int J Radiat Oncol Biol Phys 1994;29:989998.

    • Search Google Scholar
    • Export Citation
  • 110.

    Gill BS, Bernard ME, Lin JF. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol 2015;137:365372.

    • Search Google Scholar
    • Export Citation
  • 111.

    Swanick CW, Smith GL, Huo J. (P021) Delivery and outcomes of adjuvant radiation therapy in older women with node-positive vulvar cancer. Oncology (Williston Park) 2016;30(Suppl):pii: 216605.

    • Search Google Scholar
    • Export Citation
  • 112.

    Ignatov T, Eggemann H, Burger E. Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol 2016;142:489495.

    • Search Google Scholar
    • Export Citation
  • 113.

    van Beekhuizen HJ, Auzin M, van den Einden LC. Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer. Int J Gynecol Cancer 2014;24:773778.

    • Search Google Scholar
    • Export Citation
  • 114.

    Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol 2000;77:314318.

    • Search Google Scholar
    • Export Citation
  • 115.

    Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992;79:490497.

    • Search Google Scholar
    • Export Citation
  • 116.

    Kirby TO, Rocconi RP, Numnum TM. Outcomes of stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol 2005;98:309312.

    • Search Google Scholar
    • Export Citation
  • 117.

    Gonzalez Bosquet J, Magrina JF, Gaffey TA. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol 2005;97:828833.

    • Search Google Scholar
    • Export Citation
  • 118.

    Elit L, Reade CJ. Recommendations for follow-up care for gynecologic cancer survivors. Obstet Gynecol 2015;126:12071214.

  • 119.

    Salani R, Backes FJ, Fung MF. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol 2011;204:466478.

    • Search Google Scholar
    • Export Citation
  • 120.

    Hazewinkel MH, Laan ET, Sprangers MA. Long-term sexual function in survivors of vulvar cancer: a cross-sectional study. Gynecol Oncol 2012;126:8792.

    • Search Google Scholar
    • Export Citation
  • 121.

    Westin SN, Sun CC, Tung CS. Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv 2016;10:261270.

    • Search Google Scholar
    • Export Citation
  • 122.

    Mahner S, Prieske K, Grimm D. Systemic treatment of vulvar cancer. Expert Rev Anticancer Ther 2015;15:629637.

  • 123.

    Salom EM, Penalver M. Recurrent vulvar cancer. Curr Treat Options Oncol 2002;3:143153.

  • 124.

    Piura B, Masotina A, Murdoch J. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 1993;48:189195.

  • 125.

    Raffetto N, Tombolini V, Santarelli M. Radiotherapy alone and chemoirradiation in recurrent squamous cell carcinoma of the vulva. Anticancer Res 2003;23:31053108.

    • Search Google Scholar
    • Export Citation
  • 126.

    Podratz KC, Symmonds RE, Taylor WF, Williams TJ. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983;61:6374.

  • 127.

    Chiantera V, Rossi M, De Iaco P. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer 2014;24:156164.

    • Search Google Scholar
    • Export Citation
  • 128.

    Stehman FB, Bundy BN, Ball H, Clarke-Pearson DL. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1996;174:11281132.

    • Search Google Scholar
    • Export Citation
  • 129.

    Hopkins MP, Reid GC, Morley GW. The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 1990;75:10011005.

  • 130.

    Bellati F, Angioli R, Manci N. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol 2005;96:227231.

    • Search Google Scholar
    • Export Citation
  • 131.

    Cormio G, Loizzi V, Gissi F. Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma. Oncology 2009;77:281284.

  • 132.

    Kitagawa R, Katsumata N, Shibata T. Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505. J Clin Oncol 2015;33:21292135.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 1 0 0
Full Text Views 2977 2101 127
PDF Downloads 1275 1045 114
EPUB Downloads 0 0 0